As you prepare to attend the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting, we present to you a list of first-time exhibitors with product development initiatives that you may find of interest.
AlloSource was awarded U.S. Patent No. 9,186,253, Cartilage mosaic compositions and methods, for its ProChondrix® Cartilage Restoration Matrix allograft product.
OrthAlign successfully completed limited release of the OrthAlign Plus® for Total Hip Arthroplasty device for use in the direct anterior approach. The product will commence full launch at the AAOS Annual Meeting in March 2016.
Bone Therapeutics commenced a Phase IIA study for the treatment of multiple delayed-union fractures with ALLOB® allogeneic bone cell therapy product.Â
Episurf Medical received CE Mark approval for the Epioscopy™ Damage Assessment Tool, designed to support 3D visualization of knee segments, visual marking of lesions and a written assessment of structural deviations on the tibia, patella, meniscus and ACL.
Band-Lok and Kapstone Medical were issued U.S. Patent No. 9,173,685 for the Band-Lok Tether Clamp and Implantation System, designed to provide stabilization as a bone anchor during an orthopaedic procedure.
MiMedx completed its acquisition of Stability Biologics, provider of human tissue products serving the surgical, spine and orthopaedic sectors. Stability Biologics will operate as a wholly-owned subsidiary of MiMedx.